Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

ASH 2009: Novel agents for multiple myeloma

Share :

ASH 2009

3 Dec 2011
Published: 1 Mar 2010
Views: 10110
Rating:
Save
Dr Shaji Kumar - Hematology, Mayo Clinic, Rochester, USA
Dr Shaji Kumar discusses the improvement in treatment of multiple myeloma with new novel agents, specifically bortezomib and lenalidomide.

Related Videos

Patient-derived iPSCs faithfully represent the genetic diversity and cellular...
Dr Eirini Papapetrou - Icahn School of Medicine at Mount Sinai, New York, USA
Patient-derived iPSCs faithfully represent the genetic diversity and cellular architecture of AML ( Dr Eirini Papapetrou - Icahn School of Medicine at Mount Sinai, New York, USA )
28 Apr 2023
Hemopathy burden at National Cancer Center
Dr Kao Vannarith - Calmette Hospital, Phnom Penh, Cambodia
Hemopathy burden at National Cancer Center ( Dr Kao Vannarith - Calmette Hospital, Phnom Penh, Cambodia )
25 Apr 2023
ALLO-316 demonstrates encouraging anti-tumour activity for patients with...
Dr Samer Srour - The University of Texas MD Anderson Cancer Center, Houston, USA
ALLO-316 demonstrates encouraging anti-tumour activity for patients with advanced or metastatic ccRCC ( Dr Samer Srour - The University of Texas MD Anderson Cancer Center, Houston, USA )
20 Apr 2023
Choosing Wisely in hemato-medical oncology
Dr Omar Abdihamid - Garissa Cancer Centre, Garissa, Kenya
Choosing Wisely in hemato-medical oncology ( Dr Omar Abdihamid - Garissa Cancer Centre, Garissa, Kenya )
28 Mar 2023
Haemopathy burden in the National Cancer Center of Cambodia
Dr Vannarith Kao - Calmette Hospital, Phnom Penh, Cambodia
Haemopathy burden in the National Cancer Center of Cambodia ( Dr Vannarith Kao - Calmette Hospital, Phnom Penh, Cambodia )
20 Mar 2023
Choosing wisely in multiple myeloma
Dr Bishesh Poudyal - Civil Service Hospital, Kathmandu, Nepal
Choosing wisely in multiple myeloma ( Dr Bishesh Poudyal - Civil Service Hospital, Kathmandu, Nepal )
20 Mar 2023
Multiple myeloma
Dr Bishesh Poudyal - Civil Service Hospital, Kathmandu, Nepal
Multiple myeloma ( Dr Bishesh Poudyal - Civil Service Hospital, Kathmandu, Nepal )
16 Mar 2023
Choosing Wisely in multiple myeloma
Dr Hamisa Iddy - Ocean Road Cancer Institute, Dar es Salaam, Tanzania
Choosing Wisely in multiple myeloma ( Dr Hamisa Iddy - Ocean Road Cancer Institute, Dar es Salaam, Tanzania )
8 Mar 2023
ZUMA-7: Axi-cel is superior to standard of care across common prognostic...
Dr Fred Locke - Moffitt Cancer Center, Tampa, USA
ZUMA-7: Axi-cel is superior to standard of care across common prognostic subgroups in R/R LBCL ( Dr Fred Locke - Moffitt Cancer Center, Tampa, USA )
23 Dec 2022

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation